THOMPSON DAVIS & CO., INC. - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 213 filers reported holding IMMUNOMEDICS INC in Q4 2018. The put-call ratio across all filers is 1.36 and the average weighting 0.6%.

Quarter-by-quarter ownership
THOMPSON DAVIS & CO., INC. ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2018$16,000
-11.1%
7500.0%0.04%
-18.6%
Q2 2018$18,000
+63.6%
7500.0%0.04%
+48.3%
Q1 2018$11,000
-8.3%
7500.0%0.03%
+3.6%
Q4 2017$12,000
+71.4%
750
+50.0%
0.03%
+133.3%
Q3 2017$7,0000.0%500
-33.3%
0.01%
+9.1%
Q2 2017$7,0007500.01%
Other shareholders
IMMUNOMEDICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 1,711,067$2,943,0001.70%
J.P. Turner & Co Capital Mnagement, LLC 248,625$428,0000.44%
Orbimed Advisors 3,323,000$5,716,0000.06%
BALYASNY ASSET MANAGEMENT L.P. 2,004,078$3,447,0000.02%
WOLVERINE ASSET MANAGEMENT LLC 5,870$1,018,0000.02%
SIGNET FINANCIAL MANAGEMENT, LLC 44,675$77,0000.02%
SVB WEALTH LLC 195,000$335,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 288,900$497,0000.01%
J.P. Turner & Co Capital Mnagement, LLC 153,900$8,0000.01%
BALYASNY ASSET MANAGEMENT L.P. 640,400$1,101,0000.01%
View complete list of IMMUNOMEDICS INC shareholders